Instituto Rosenbusch S.A. (ROSE) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.542x

Based on the latest financial reports, Instituto Rosenbusch S.A. (ROSE) has a cash flow conversion efficiency ratio of -1.542x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AR$811.18 Million ≈ $586.98K USD) by net assets (AR$-526.19 Million ≈ $-380.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Instituto Rosenbusch S.A. strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Instituto Rosenbusch S.A. - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Instituto Rosenbusch S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. See Instituto Rosenbusch S.A. book value and equity for net asset value and shareholders' equity analysis.

Instituto Rosenbusch S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Instituto Rosenbusch S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Mantle Minerals Ltd
AU:MTL
-0.118x
TIMES CHINA HLDGS HD -10
F:T2H
N/A
Mint Corp
V:MIT
0.055x
Maple Peak Investments Inc
V:MAP
-0.062x
China Natural Resources Inc
NASDAQ:CHNR
-0.048x
Golden Goliath Resources Ltd.
V:GNG
-0.262x
Manchester and London Investment Trust plc
LSE:MNL
-0.004x
PMPG Polskie Media S.A.
WAR:PGM
-0.105x

Annual Cash Flow Conversion Efficiency for Instituto Rosenbusch S.A. (2000–2025)

The table below shows the annual cash flow conversion efficiency of Instituto Rosenbusch S.A. from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Instituto Rosenbusch S.A..

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 AR$-526.19 Million
≈ $-380.75K
AR$409.89 Million
≈ $296.60K
-0.779x -531.50%
2024-12-31 AR$3.99 Billion
≈ $2.89 Million
AR$720.31 Million
≈ $521.22K
0.181x +147.75%
2023-12-31 AR$4.55 Billion
≈ $3.29 Million
AR$331.37 Million
≈ $239.78K
0.073x -40.74%
2022-12-31 AR$400.51 Million
≈ $289.81K
AR$49.25 Million
≈ $35.64K
0.123x -58.04%
2021-12-31 AR$199.19 Million
≈ $144.13K
AR$58.37 Million
≈ $42.24K
0.293x -34.20%
2020-12-31 AR$147.69 Million
≈ $106.87K
AR$65.78 Million
≈ $47.60K
0.445x -13.10%
2019-12-31 AR$115.52 Million
≈ $83.59K
AR$59.20 Million
≈ $42.84K
0.513x +439.11%
2018-12-31 AR$145.95 Million
≈ $105.61K
AR$-22.06 Million
≈ $-15.96K
-0.151x -272.55%
2017-12-31 AR$86.58 Million
≈ $62.65K
AR$-3.51 Million
≈ $-2.54K
-0.041x -121.32%
2016-12-31 AR$83.24 Million
≈ $60.23K
AR$15.84 Million
≈ $11.46K
0.190x +252.20%
2015-12-31 AR$70.62 Million
≈ $51.10K
AR$-8.83 Million
≈ $-6.39K
-0.125x -192.60%
2014-12-31 AR$68.24 Million
≈ $49.38K
AR$9.21 Million
≈ $6.67K
0.135x -32.36%
2011-12-31 AR$56.25 Million
≈ $40.70K
AR$11.23 Million
≈ $8.12K
0.200x +96.02%
2010-12-31 AR$50.20 Million
≈ $36.32K
AR$5.11 Million
≈ $3.70K
0.102x +352.72%
2009-12-31 AR$46.95 Million
≈ $33.97K
AR$1.06 Million
≈ $764.13
0.022x -87.71%
2008-12-31 AR$45.65 Million
≈ $33.03K
AR$8.36 Million
≈ $6.05K
0.183x +811.58%
2007-12-31 AR$37.50 Million
≈ $27.13K
AR$753.00K
≈ $544.87
0.020x -65.96%
2006-12-31 AR$35.97 Million
≈ $26.03K
AR$2.12 Million
≈ $1.54K
0.059x -61.58%
2005-12-31 AR$34.13 Million
≈ $24.70K
AR$5.24 Million
≈ $3.79K
0.154x -9.98%
2003-12-31 AR$28.27 Million
≈ $20.45K
AR$4.82 Million
≈ $3.49K
0.171x +122.37%
2002-12-31 AR$24.17 Million
≈ $17.49K
AR$1.85 Million
≈ $1.34K
0.077x +268.10%
2000-12-31 AR$11.90 Million
≈ $8.61K
AR$248.00K
≈ $179.45
0.021x --

About Instituto Rosenbusch S.A.

BA:ROSE Argentina Drug Manufacturers - Specialty & Generic
Market Cap
$5.12 Million
AR$7.07 Billion ARS
Market Cap Rank
#28477 Global
#77 in Argentina
Share Price
AR$166.00
Change (1 day)
-0.90%
52-Week Range
AR$118.25 - AR$380.00
All Time High
AR$380.00
About

Instituto Rosenbusch S.A. manufactures and sells veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious kera… Read more